Cell Therapy Manufacturing CDMOs in United States
22 published
22 published CDMOs match Cell Therapy Manufacturing in United States.
Locations in this set include United States, Japan, United Kingdom, China, Denmark, and Germany.
Capabilities that show up most often in this set: Cell Therapy, Gene Therapy, AAV / Viral Vector Platform, Vaccine, and Biologics (Monoclonal Antibodies).
Matching companies
RoslinCTRoslinCT is a cell and gene therapy CDMO offering cGMP iPSC banking, process and analytical development, and clinical and commercial manufacturing for autologous and allogeneic programs.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Markdown mirror: /services/cell-therapy-manufacturing/us.md